Diane Weiser

SVP, Corporate Communications and Investor Relations at Cytokinetics

Diane Weiser is the SVP, Corporate Communications and Investor Relations at Cytokinetics. Weiser has over two decades of experience in the public relations industry.

Weiser began their career at Burson-Marsteller in 1989 as a Manager, Client Service. Diane left in 1994 to join Makovsky & Company as their Head of Healthcare Practice. Weiser was with Makovsky for five years before moving to Ketchum Public Relations in 1999. At Ketchum, Diane served as the SVP, Healthcare Practice Leader.

In 2004, Weiser joined W2O Group as their Leader, Health. Diane spent over 10 years with the company, helping to grow it into a successful network of marketing and communications firms. Weiser left W2O in 2015 to join Cytokinetics as their SVP, Corporate Communications and Investor Relations.

Diane Weiser has a BA in Communications/Public Relations from American University.

Diane Weiser reports to Robert Blum, President & CEO. They are on a team with Andrew Callos - EVP, Chief Commercial Officer, Fady I. Malik - EVP, Research and Development, and Diann Potestio - VP, Global Value, Access & Distribution.

Links

Timeline

  • SVP, Corporate Communications and Investor Relations

    Current role

View in org chart